A New Method for Synthesizing Radiation Dose-Response Data From Multiple Trials Applied to Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 1066-1071

  Diez, Patricia ^a   Vogelius, Ivan S ^b,c   Bentzen, Søren M ^c  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b LILLEBAELT HOSPITAL   (Denmark)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Dose response; Prostate cancer; Radiotherapy; Systematic review

Indexed keywords

BEST ESTIMATES; BIOCHEMICAL CONTROL; CLINICAL TRIAL; CONFIDENCE INTERVAL; DOSE RESPONSE; DOSE-ESCALATION STUDY; DOSE-RESPONSE CURVES; HIGH-RISK PATIENTS; MEDLINE; NOVEL METHODS; PROSTATE CANCER; PROSTATE CANCERS; RADIATION DOSE; RANDOMIZED TRIAL; STAGE MIGRATION; STATISTICALLY SIGNIFICANT DIFFERENCE; STUDY DESIGN; SYSTEMATIC REVIEW; TREATMENT TECHNIQUES;

DATABASE SYSTEMS; RADIOTHERAPY;

RISK PERCEPTION;

ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DOSIMETRY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZATION; SYSTEMATIC REVIEW;

ALGORITHMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 77953576200     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.013     Document Type: Article

References (24)

1. Cahlon O., Hunt M., and Zelefsky M.J. Intensity-modulated radiation therapy: Supportive data for prostate cancer. Semin Radiat Oncol 18 (2008) 48-57
2. Ghilezan M., Yan D., Liang J., et al. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60 (2004) 1602-1610
3. Kupelian P.A., Langen K.M., Willoughby T.R., et al. Image-guided radiotherapy for localized prostate cancer: Treating a moving target. Semin Radiat Oncol 18 (2008) 58-66
4. Fowler J.F., Ritter M.A., Chappell R.J., et al. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 56 (2003) 1093-1104
5. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 23 (1984) 379-391
6. Bentzen S.M., and Tucker S.L. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 71 (1997) 531-542
7. Lukka H., Hayter C., Julian J.A., et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 23 (2005) 6132-6138
8. Valdagni R., Italia C., Montanaro P., et al. Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy. Radiother Oncol 75 (2005) 74-82
9. Review Manager (RevMan). 5.0 ed. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.
10. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
11. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
12. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
13. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
14. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46 (2000) 823-832
15. Kupelian P., Kuban D., Thames H., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61 (2005) 415-419
16. Lyons J.A., Kupelian P.A., Mohan D.S., et al. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 55 (2000) 85-90
17. Pollack A., Smith L.G., and von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48 (2000) 507-512
18. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
19. Cheung R., Tucker S.L., Lee A.L., et al. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 14-19
20. Vicini F.A., Kestin L.L., and Martinez A.A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 553-561
21. Bentzen S.M. Radiobiological considerations in the design of clinical trials. Radiother Oncol 32 (1994) 1-11
22. Bentzen S.M., and Ritter M.A. The alpha/beta ratio for prostate cancer: What is it, really?. Radiother Oncol 76 (2005) 1-3
23. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
24. Consensus statement. Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041